Protective effect of Zn-pipemidate on experimental gastric ulcer and its mechanism
Xiao Liu
Abstract
Xiao Liu
Abstract
AIM: To study protective effest of Zn-pipemidate on experimental gastric ulcer and its mechanism. METHODS: Pylous-ligated, stess-induced, acetic acid-induced and reserpine-induced gastric ulcers in rats or mice were used in experiment. Rats or mice were randomly divided into five groups including carboxymethylcellulose (CMC), cimetidine and three doses of Zn-pipemidate ( 0.025, 0.05, 0.1 g·kg -1). The drugs were given ig, once a day, for 5d. Gastric juice, out-put of pan-acid, pepsin activity and the volume of mucus gastric wall were determined in pylorus-ligated gastric ulcer in rats. RESULTS: Zn-pipemidate could inhibited the formation of all gastric ulcer models in a dose-dependent manner. All of the three doses of Zn-pipemidate groups could reduce out-put of pan-acid (P 0.01) and pepsin activity, and increase the volume of mucus gastric wall (P 0.01). CONCLUSION: Zn-pipemidate can protect experimental gastric ulcer. Its mechanism is related to increasing protective factors and reducing damaging factors of gastric mucosa.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To study protective effest of Zn-pipemidate on experimental gastric ulcer and its mechanism. METHODS: Pylous-ligated, stess-induced, acetic acid-induced and reserpine-induced gastric ulcers in rats or mice were used in experiment. Rats or mice were randomly divided into five groups including carboxymethylcellulose (CMC), cimetidine and three doses of Zn-pipemidate ( 0.025, 0.05, 0.1 g·kg -1). The drugs were given ig, once a day, for 5d. Gastric juice, out-put of pan-acid, pepsin activity and the volume of mucus gastric wall were determined in pylorus-ligated gastric ulcer in rats. RESULTS: Zn-pipemidate could inhibited the formation of all gastric ulcer models in a dose-dependent manner. All of the three doses of Zn-pipemidate groups could reduce out-put of pan-acid (P 0.01) and pepsin activity, and increase the volume of mucus gastric wall (P 0.01). CONCLUSION: Zn-pipemidate can protect experimental gastric ulcer. Its mechanism is related to increasing protective factors and reducing damaging factors of gastric mucosa.
Key concepts: Pepsin, Cimetidine, Reserpine, Mucus, Pylorus, Gastric mucosa, Pharmacology, Acetic acid